IQP-CL-101 in IBS Management

Update Il y a 4 ans
Reference: NCT01774825

Woman and Man

  • | Country :
  • Germany
  • | organs :
  • -
  • | Specialty :
  • -

Extract

After 2 weeks of run-in period, subjects are randomized to either IQP-CL-101 or a matching placebo. Over 8 weeks, the subjects are monitored for improvements in IBS symptoms


Inclusion criteria

  • Irritable bowel syndrome

Links